1-(5-O-BENZOYL-2,3-DIDEOXY-3-C-TRIFLUOROMETHYL-BETA-D-GLYCERO-PENT-2-ENO-FURANOSYL)-URACIL
Compound with spectra: 2 NMR
| SpectraBase Compound ID | 1NpdUHRn2xE |
|---|---|
| InChI | InChI=1S/C17H13F3N2O5/c18-17(19,20)11-8-14(22-7-6-13(23)21-16(22)25)27-12(11)9-26-15(24)10-4-2-1-3-5-10/h1-8,12,14H,9H2,(H,21,23,25)/t12-,14-/m0/s1 |
| InChIKey | MXWCPXNHVXHGFQ-JSGCOSHPSA-N |
| Mol Weight | 382.3 g/mol |
| Molecular Formula | C17H13F3N2O5 |
| Exact Mass | 382.077656 g/mol |
| Enantiomer InChIKey | MXWCPXNHVXHGFQ-TZMCWYRMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-(5-O-TBDPS-2,3-DIDEOXY-3-METHYL-BETA-D-GLYCERO-PENT-2-ENOFURANOSYL)-URACYL
N(4)-ACETYL-1-[5-O-(tert-BUTYL-DIPHENYLSILYL)-2,3-DIDEOXY-beta-D-GLYCERO-PENTO-2-ENOFURANOSYL)-CYTOSINE
5-BENZYLOXYMETHYL-1-(2,3-DIDEOXY-5-O-(4-METHYLBENZOYL)-ALPHA-D-GLYCERO-PENTOFURANOSYL)-CYTOSINE
5-BENZYLOXYMETHYL-1-(2',3'-DIDEOXY-5-O-(4-METHYLBENZOYL)-CYTIDINE
Dibenzoyldeoxyuridine
1-(2',3'-DIDEOXY-5-O-(4-METHYLBENZOYL)-ALPHA-D-GLYCERO-PENTOFURANOSYL)-5-PENTYLOXYMETHYLCYTOSINE
2',3'-DIDEOXY-5-O-(4-METHYLBENZOYL)-5-PENTYLOXYMETHYLCYTIDINE
(2'R)-D-5'-O-(tert-butyldimethylsilyl)-2',3'-dideoxy-2'-trifluoromethyluridine isomer
(2'S)-D-5'-O-(tert-butyldimethylsilyl)-2',3'-dideoxy-2'-trifluoromethyluridine isomer
4-Methoxy-1-(3'-O-methyl-.beta.-D-ribofuranosyl)-2-pyrimidinone
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and studies of 3′-C-trifluoromethyl nucleoside analogues bearing adenine or cytosine as the base | Bioorganic & Medicinal Chemistry | 2002 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.